1CMR Pro

Mycardium AI Limited's 1CMR Pro is a Class II medical image management and processing system designed to display, analyze, and transfer DICOM cardiovascular images from CMR scanners for assessing cardiac structure, function, and flow. It employs AI analysis, rigorously validated through comprehensive non-clinical and clinical testing, demonstrating superior accuracy and precision in cardiac measurements compared to human analysis and existing software.

A determination has been made regarding Mycardium AI Limited's 1CMR Pro, a Class II medical image management and processing system. This software is designed to display, analyze, and transfer DICOM cardiovascular images obtained from Cardiovascular Magnetic Resonance (CMR) scanners, focusing on cardiac structure, function, and flow. It is compatible with 1.5T and 3T CMR acquisitions and is intended for use in both healthy patients and those with suspected cardiac disease, though its AI analysis components are not for use in individuals with known congenital cardiac abnormalities, children under 18, or those with pacemakers. The review concluded that the 1CMR Pro is comparable to existing legally marketed devices for its stated indications for use, allowing it to be marketed. This decision was supported by comprehensive non-clinical and clinical testing. Non-clinical assessments included risk management, software verification and validation, and usability engineering, ensuring compliance with relevant standards. Performance testing on independent validation datasets demonstrated the device's acceptable accuracy and precision. This included a study on 64 adults for accuracy, which found the device's AI performance to be superior or exceeding that of human analysis for most metrics. Precision testing on 110 adults further showed the AI to be superior for various left ventricular measurements compared to both human analysis and previously available software. The manufacturer is reminded that the device remains subject to general controls and other applicable requirements, including those for quality systems, device registration and listing, labeling, and adverse event reporting.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific congenital cardiac abnormalities preclude the use of 1CMR Pro's AI analysis, and what are the risks if used in these populations?; How does the 1CMR Pro's AI performance compare to human analysis in cases of highly complex or atypical cardiac anatomies?; What is the long-term clinical impact of integrating 1CMR Pro into diagnostic workflows regarding patient outcomes and management strategies?; Are there ongoing studies or plans to expand the AI analysis components of 1CMR Pro to pediatric populations or individuals with pacemakers?; What are the precise quantitative metrics for left ventricular measurements where 1CMR Pro's AI demonstrated superiority over both human analysis and previously available software?